Patents by Inventor Brian M. Murphy
Brian M. Murphy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20260008599Abstract: Tamper-evident plastic container comprises a base portion having a sidewall and a base flange extending outwardly from at least a portion of the sidewall, and a lid portion having a lid tab joined to the base flange by a hinge, wherein the lid portion has an open position and a closed position. The lid portion is configured to lockingly engage the base portion in the closed position. One of the base flange or the lid tab has a non-linear path of weakness formed therein to define a frangible connection, wherein the frangible connection is configured to be ruptured to initially open the lid portion from the closed position. The non-linear path of weakness is spaced from the hinge to define a tamper indicator region between the non-linear path of weakness and the hinge, wherein the tamper indicator region remains joined to the hinge after the frangible connection is ruptured.Type: ApplicationFiled: July 8, 2025Publication date: January 8, 2026Applicant: PACTIV LLCInventor: Brian M. Murphy
-
Patent number: 12378049Abstract: Tamper-evident plastic container comprises a base portion having a sidewall and a base flange extending outwardly from at least a portion of the sidewall, and a lid portion having a lid tab joined to the base flange by a hinge, wherein the lid portion has an open position and a closed position. The lid portion is configured to lockingly engage the base portion in the closed position. One of the base flange or the lid tab has a non-linear path of weakness formed therein to define a frangible connection, wherein the frangible connection is configured to be ruptured to initially open the lid portion from the closed position. The non-linear path of weakness is spaced from the hinge to define a tamper indicator region between the non-linear path of weakness and the hinge, wherein the tamper indicator region remains joined to the hinge after the frangible connection is ruptured.Type: GrantFiled: May 29, 2024Date of Patent: August 5, 2025Assignee: PACTIV LLCInventor: Brian M. Murphy
-
Publication number: 20250100766Abstract: Tamper-evident plastic container comprises a base portion having a sidewall and a base flange extending outwardly from at least a portion of the sidewall, and a lid portion having a lid tab joined to the base flange by a hinge, wherein the lid portion has an open position and a closed position. The lid portion is configured to lockingly engage the base portion in the closed position. One of the base flange or the lid tab has a non-linear path of weakness formed therein to define a frangible connection, wherein the frangible connection is configured to be ruptured to initially open the lid portion from the closed position. The non-linear path of weakness is spaced from the hinge to define a tamper indicator region between the non-linear path of weakness and the hinge, wherein the tamper indicator region remains joined to the hinge after the frangible connection is ruptured.Type: ApplicationFiled: May 29, 2024Publication date: March 27, 2025Applicant: PACTIV LLCInventor: Brian M. Murphy
-
Patent number: 12024348Abstract: Tamper-evident plastic container comprises a base portion having a base flange and a lid portion having a lid tab joined to the base flange by a hinge, wherein the lid portion has at least one grip tab extending outwardly beyond the base flange. The lid portion is configured to lockingly engage the base portion in a closed position. One of the base flange or the lid tab has a path of weakness formed therein to define a frangible connection, wherein the frangible connection is configured to be ruptured to initially open the lid portion from the closed position. The path of weakness is spaced from the hinge to define a tamper indicator region between the path of weakness and the hinge, wherein the tamper indicator region remains joined to the hinge after the frangible connection is ruptured. Methods of containing a product in a tamper-evident container are also disclosed.Type: GrantFiled: February 10, 2022Date of Patent: July 2, 2024Assignee: PACTIV LLCInventor: Brian M. Murphy
-
Publication number: 20220411147Abstract: Tamper-evident plastic container comprises a base portion having a sidewall and a base flange extending outwardly from at least a portion of the sidewall, as well as a lid portion having a lid tab joined to the base flange by a hinge, wherein the lid portion has an open position and a closed position. The lid portion is configured to lockingly engage the base portion in the closed position. One of the base flange or the lid tab has a non-linear path of weakness formed therein to define a frangible connection, wherein the frangible connection is configured to be ruptured to initially open the lid portion from the closed position. The non-linear path of weakness is spaced from the hinge to define a tamper indicator region between the non-linear path of weakness and the hinge, wherein the tamper indicator region remains joined to the hinge after the frangible connection is ruptured. Methods of containing a product in a tamper-evident container are also disclosed.Type: ApplicationFiled: February 10, 2022Publication date: December 29, 2022Applicant: PACTIV LLCInventor: Brian M. Murphy
-
Patent number: 11279534Abstract: Tamper-evident plastic container comprises a base portion having a sidewall and a base flange, and a lid portion having a lid tab joined to the base flange by a hinge, wherein the lid portion has an open and a closed position. The lid portion is configured to lockingly engage the base portion in the closed position. One of the base flange or the lid tab has a non-linear path of weakness formed therein to define a frangible connection, wherein the frangible connection is configured to be ruptured to initially open the lid portion from the closed position. The non-linear path of weakness is spaced from the hinge to define a tamper indicator region between the non-linear path of weakness and the hinge, wherein the tamper indicator region remains joined to the hinge after the frangible connection is ruptured. Methods of containing a product in a tamper-evident container are also disclosed.Type: GrantFiled: April 16, 2019Date of Patent: March 22, 2022Assignee: PACTIV LLCInventor: Brian M. Murphy
-
Publication number: 20200331674Abstract: Tamper-evident plastic container comprises a base portion having a sidewall and a base flange extending outwardly from at least a portion of the sidewall, as well as a lid portion having a lid tab joined to the base flange by a hinge, wherein the lid portion has an open position and a closed position. The lid portion is configured to lockingly engage the base portion in the closed position. One of the base flange or the lid tab has a non-linear path of weakness formed therein to define a frangible connection, wherein the frangible connection is configured to be ruptured to initially open the lid portion from the closed position. The non-linear path of weakness is spaced from the hinge to define a tamper indicator region between the non-linear path of weakness and the hinge, wherein the tamper indicator region remains joined to the hinge after the frangible connection is ruptured. Methods of containing a product in a tamper-evident container are also disclosed.Type: ApplicationFiled: April 16, 2019Publication date: October 22, 2020Applicant: PACTIV LLCInventor: Brian M. Murphy
-
Patent number: 10195281Abstract: The present application relates to formulations of anti-CD105 antibodies, antigen-binding fragments thereof, and uses thereof. Another aspect relates to pre-filled syringes of the formulations of anti-CD105 antibodies or antigen-binding fragments thereof. Another aspect relates to the use of the formulations to reduce one or more signs or symptoms of an angiogenesis-related disorder such as cancers and ophthalmologic diseases.Type: GrantFiled: September 5, 2013Date of Patent: February 5, 2019Assignee: Tracon Pharmaceuticals, Inc.Inventors: Suzanne Benedict, Mark Cornell Manning, Brian M. Murphy, Sharon Real, Charles Theuer
-
Publication number: 20180311359Abstract: The present application relates to formulations of anti-CD105 antibodies, antigen-binding fragments thereof, and uses thereof. Another aspect relates to pre-filled syringes of the formulations of anti-CD105 antibodies or antigen-binding fragments thereof. Another aspect relates to the use of the formulations to reduce one or more signs or symptoms of an angiogenesis-related disorder such as cancers and ophthalmologic diseases.Type: ApplicationFiled: July 13, 2018Publication date: November 1, 2018Inventors: Suzanne Benedict, Mark Cornell Manning, Brian M. Murphy, Sharon Real, Charles Theuer
-
Publication number: 20150209430Abstract: The present application relates to formulations of anti-CD105 antibodies, antigen-binding fragments thereof, and uses thereof. Another aspect relates to pre-filled syringes of the formulations of anti-CD105 antibodies or antigen-binding fragments thereof. Another aspect relates to the use of the formulations to reduce one or more signs or symptoms of an angiogenesis-related disorder such as cancers and ophthalmologic diseases.Type: ApplicationFiled: September 5, 2013Publication date: July 30, 2015Applicant: Tracon Pharmaceuticals, Inc.Inventors: Suzanne Benedict, Mark Cornell Manning, Brian M. Murphy, Sharon Real, Charles Theuer
-
Patent number: D920100Type: GrantFiled: April 16, 2019Date of Patent: May 25, 2021Assignee: PACTIV LLCInventor: Brian M. Murphy
-
Patent number: D961383Type: GrantFiled: May 21, 2021Date of Patent: August 23, 2022Assignee: PACTIV LLCInventor: Brian M. Murphy
-
Patent number: D997724Type: GrantFiled: August 11, 2022Date of Patent: September 5, 2023Assignee: PACTIV LLCInventor: Brian M. Murphy